Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.

OVERLAP
58%
OVERLAP
BY WEIGHT
21
# OF OVERLAPPING
HOLDINGS
BBH
26
HOLDINGS
88%
ALSO IN IBB
IBB
251
HOLDINGS
10%
ALSO IN BBH
SECTOR DRIFT (BBH minus IBB)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
Company | Weight in BBH |
Weight in IBB |
Overlap | |
---|---|---|---|---|
GILEAD SCIENCES INC | 12.7% | 7.3% | 7.3% | |
AMGEN INC | 14.4% | 6.7% | 6.7% | |
VERTEX PHARMACEUTICALS INC | 8.6% | 6.2% | 6.2% | |
ALNYLAM PHARMACEUTICALS INC | 6.5% | 6.2% | 6.2% | |
REGENERON PHARMACEUTICALS | 5.0% | 6.2% | 5.0% |
BBH Overweight Relative to IBB
AMGEN INC | 7.7% | |
GILEAD SCIENCES INC | 5.4% | |
ICON PLC | 3.5% | |
ARGENX SE ADR | 3.0% | |
INSMED INC | 2.4% | |
VERTEX PHARMACEUTICALS INC | 2.4% | |
NATERA INC | 1.9% | |
NEUROCRINE BIOSCIENCES INC | 1.5% | |
IQVIA HOLDINGS INC | 1.5% | |
QIAGEN NV | 1.5% |
BBH Underweight Relative to IBB
METTLER-TOLEDO INTERNATIONAL | -2.8% | |
UNITED THERAPEUTICS CORP | -1.9% | |
WATERS CORP | -1.9% | |
MEDPACE HOLDINGS, INC. | -1.2% | |
GENMAB A/S SPONSORED ADR | -1.2% | |
REGENERON PHARMACEUTICALS | -1.2% | |
EXELIXIS INC | -1.1% | |
IONIS PHARMACEUTICALS, INC. | -1.0% | |
HALOZYME THERAPEUTICS INC | -1.0% | |
MADRIGAL PHARMACEUTICALS, INC. | -0.9% |